BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 24155936)

  • 1. The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21(WAF1/CIP1) expression.
    Liu Z; Sun M; Lu K; Liu J; Zhang M; Wu W; De W; Wang Z; Wang R
    PLoS One; 2013; 8(10):e77293. PubMed ID: 24155936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G₁/S transition and apoptosis by targeting p21(WAF1/CIP1).
    Wang H; Zhu LJ; Yang YC; Wang ZX; Wang R
    Br J Cancer; 2014 Jul; 111(2):339-54. PubMed ID: 24921914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
    Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z
    PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA RP3-326I13.1 promotes cisplatin resistance in lung adenocarcinoma by binding to HSP90B and upregulating MMP13.
    Zhou H; Huang X; Shi W; Xu S; Chen J; Huang K; Wang Y
    Cell Cycle; 2022 Jul; 21(13):1391-1405. PubMed ID: 35298351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-326 reverses chemoresistance in human lung adenocarcinoma cells by targeting specificity protein 1.
    Li J; Li S; Chen Z; Wang J; Chen Y; Xu Z; Jin M; Yu W
    Tumour Biol; 2016 Oct; 37(10):13287-13294. PubMed ID: 27460077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
    Cheng C; Qin Y; Zhi Q; Wang J; Qin C
    Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non‑coding RNA AK001796 contributes to cisplatin resistance of non‑small cell lung cancer.
    Liu B; Pan CF; Ma T; Wang J; Yao GL; Wei K; Chen YJ
    Mol Med Rep; 2017 Oct; 16(4):4107-4112. PubMed ID: 29067469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroquine reverses chemoresistance via upregulation of p21
    Hwang JR; Kim WY; Cho YJ; Ryu JY; Choi JJ; Jeong SY; Kim MS; Kim JH; Paik ES; Lee YY; Han HD; Lee JW
    Cell Death Dis; 2020 Dec; 11(12):1034. PubMed ID: 33277461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1.
    Zhang Y; Ai H; Fan X; Chen S; Wang Y; Liu L
    Biol Res; 2020 Apr; 53(1):18. PubMed ID: 32349783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased sensitivity of human lung adenocarcinoma cells to cisplatin associated with downregulated contactin-1.
    Zhang R; Yao W; Qian P; Li Y; Jiang C; Ao Z; Qian G; Wang C; Wu G; Li J; Ji F; Xu J
    Biomed Pharmacother; 2015 Apr; 71():172-84. PubMed ID: 25960233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of long non-coding RNA H19 expression with cisplatin-resistance and clinical outcome in lung adenocarcinoma.
    Wang Q; Cheng N; Li X; Pan H; Li C; Ren S; Su C; Cai W; Zhao C; Zhang L; Zhou C
    Oncotarget; 2017 Jan; 8(2):2558-2567. PubMed ID: 27911863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA XIST promotes human lung adenocarcinoma cells to cisplatin resistance via let-7i/BAG-1 axis.
    Sun J; Pan LM; Chen LB; Wang Y
    Cell Cycle; 2017; 16(21):2100-2107. PubMed ID: 28961027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of LRRC8A protects human ovarian and alveolar carcinoma cells against Cisplatin-induced expression of p53, MDM2, p21Waf1/Cip1, and Caspase-9/-3 activation.
    Sørensen BH; Nielsen D; Thorsteinsdottir UA; Hoffmann EK; Lambert IH
    Am J Physiol Cell Physiol; 2016 Jun; 310(11):C857-73. PubMed ID: 26984736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA RP11-838N2.3 Promoted Cisplatin Resistance in Lung Adenocarcinoma.
    Chen J; Jiang F; Hu L; Zhang F; Wang J; Huang K; Wang Y
    Biomed Res Int; 2020; 2020():2806042. PubMed ID: 32626737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant Long Noncoding RNAs Expression Profiles Affect Cisplatin Resistance in Lung Adenocarcinoma.
    Hu L; Chen J; Zhang F; Wang J; Pan J; Chen J; Wang Y
    Biomed Res Int; 2017; 2017():7498151. PubMed ID: 29279851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-324-3p reverses cisplatin resistance by inducing GPX4-mediated ferroptosis in lung adenocarcinoma cell line A549.
    Deng SH; Wu DM; Li L; Liu T; Zhang T; Li J; Yu Y; He M; Zhao YY; Han R; Xu Y
    Biochem Biophys Res Commun; 2021 Apr; 549():54-60. PubMed ID: 33662669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
    Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
    Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA damage responsive miR-33b-3p promoted lung cancer cells survival and cisplatin resistance by targeting p21
    Xu S; Huang H; Chen YN; Deng YT; Zhang B; Xiong XD; Yuan Y; Zhu Y; Huang H; Xie L; Liu X
    Cell Cycle; 2016 Nov; 15(21):2920-2930. PubMed ID: 27559850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of lncRNA UCA1-related downstream pathways and molecules of cisplatin resistance in lung adenocarcinoma.
    Zhou H; Shen Q; Fu J; Jiang F; Wang L; Wang Y
    J Clin Lab Anal; 2020 Aug; 34(8):e23312. PubMed ID: 32249461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Let-7c governs the acquisition of chemo- or radioresistance and epithelial-to-mesenchymal transition phenotypes in docetaxel-resistant lung adenocarcinoma.
    Cui SY; Huang JY; Chen YT; Song HZ; Feng B; Huang GC; Wang R; Chen LB; De W
    Mol Cancer Res; 2013 Jul; 11(7):699-713. PubMed ID: 23562878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.